Blog Category Archives

Showing entries for:

My Time as METAvivor’s President

February 10, 2020  /  BY Beth Fairchild

Sample

Our first guest blogger is METAvivor's Immediate Past President, Beth Fairchild. Beth talks about her time as METAvivor's president and how she puts research at the forefront of every advocacy opportunity knowing that it is the only way the future can be changed.

Continue

Barbara Bigelow Takes Over the METAvivor Blog

February 7, 2020  /  BY Barbara Bigelow

Sample

Barbara Bigelow is a member of the METAvivor Board of Directors and a metastatic breast cancer patient advocate. She's taking over the METAvivor blog and wants to hear from you. Share your ideas or short content for the chance to be featured as a METAvivor guest blogger. 

Continue

METAVIVOR ANNOUNCES ADDITIONAL METASTATIC BREAST CANCER RESEARCH AWARDS FOR 2019

February 7, 2020  /  BY METAvivor Board of Directors

Sample

METAvivor Research and Support announces six additional new grant awards for metastatic breast cancer research totaling $1,200,000.  2019 was a banner year for METAvivor and is a result of increasing awareness of metastatic breast cancer These grants hold promise for future treatments and therapies that will one day, change metastatic breast cancer from a terminal disease to one that is chronic yet manageable.

Continue

Kaitlyn Hanna Shares Her Story

January 13, 2020  /  BY Kaitlyn Hanna

Kaitlyn Hanna is our guest blogger. Kaitlyn is 28 years old and has had many setbacks, including the rare metastasis in the cerebral spinal fluid. Kaitlyn asked to share her story so others may know that metastasis can be very tricky and rare events can happen. 

Continue

METAVIVOR ANNOUNCES 2019 GRANT AWARDS FOR METASTATIC BREAST CANCER RESEARCH

December 30, 2019  /  BY METAvivor Board Members

Sample

METAvivor Research and Support announces 32 new grant awards for metastatic breast cancer research totaling $5,000,000.  This banner year for grant awards is a result of increasing awareness of metastatic breast cancer and the lack of funding for research targeted specifically for metastatic breast cancer. The grants hold promise for future treatments and therapies that will have a significant and positive impact for metastatic breast cancer.

Continue

Page